Idorsia aims to be Europe’s leading biopharmaceutical company, with a strong scientific core. We provide regular updates on the progress being made towards this goal. This section of the website provides journalists with additional material to support the generation of articles.
News
| 01 Apr 2021 | |
| 26 Mar 2021 | |
| 19 Mar 2021 |
Events
| Event | When |
| J.P. Morgan Healthcare conference |
Press release |
| Credit Suisse London Global Healthcare Conference | March 2-4, 2021 |
| First Quarter 2021 Financial Results reporting* | April 22, 2021 |
| Annual General Meeting of Shareholders | May 12, 2021 |
| Jefferies Healthcare Conference | June 1-4, 2021 |
| Goldman Sachs Global Healthcare Conference | June 8-10, 2021 |
| Citi European Healthcare Conference | June 15-16, 2021 |
| dbAccess Berlin Conference | June 16-17, 2021 |
| J.P. Morgan European Healthcare Conference | June 17, 2021 |
| Half-Year 2021 Financial Results reporting* | July 27, 2021 |
| Nine-months 2021 Financial Results reporting* | October 26, 2021 |
*We will be in a silent period for 10 days ahead of the financial reporting.
Stay informed
Idorsia offers an electronic ‘Stay Informed’ service where subscribers can automatically receive updates via e-mail or SMS alert.
Social Media
Idorsia is active on social media – follow our channels to get a more personal view on the company.
Media center
Idorsia provides images, fact sheets and B-roll to download or support you with your article.
Contact
Andrew C. Weiss
Senior Vice President, Head of Investor Relations and Corporate Communications
Media Relations
Resources in German
Als schweizerisches Unternehmen stellen wir interessierten Personen auf dieser Seite wesentliche Informationen über unser Unternehmen in deutscher Sprache zur Verfügung.